Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Pre-order your Brochure

14th Annual Patient Summit USA 2017 November 2 - 3, 2017|Philadelphia, USA

Last year's industry-leading speaker line-up

We are currently pulling together the agenda and speaker line-up for 2017. If you would like to be part of the research or join the speaking line-up, please put forward your suggestions to nwilliams@eyeforpharma.com

Pharma Faculty

Lisa Egbuonu-Davis

Lisa Egbuonu-Davis

VP, Global Patient Centered Outcomes and Solution, Sanofi

More information coming soon...

Dr. Christopher Boerner

Dr. Christopher Boerner

President and Head of US Commercial, Bristol-Myers Squibb

Dr. Christopher Boerner is currently the President and Head of the U.S. Commercial business at Bristol-Myers Squibb. He joined BMS in February 2015. Prior to this role, Dr. Boerner served as the Executive Vice President of Commercial for Seattle Genetics, Inc., where he was responsible for leading all commercial activities for the company. Previously, he was its Senior Vice President of Commercial and its Vice President of Marketing. Before joining Seattle Genetics, Dr. Boerner was with Dendreon Corporation, where he led the marketing team.From 2002 to 2010, he was with Genentech, a member of the Roche Group, where he served in a variety of commercial roles, including Director of Marketing on Avastin, Director of Avastin franchise strategy and Associate Director of Oncology Market Development.Prior to Genentech, Dr. Boerner was with McKinsey & Company, a global strategic management consulting firm, where he served global pharmaceutical and biotechnology clients.

Dr. Boerner received his PhD and M.A. in Business Administration from the Haas School of Business at the University of California, Berkeley, and holds an A.B. in Economics and History from Washington University in St. Louis.

Elizabeth Turcotte

Elizabeth Turcotte

Director, Patient Hub, BMS

Elizabeth Turcotte is the Director of the Patient Hub at Bristol-Myers Squibb. In this role, she supports the entire organization in delivering improved patient experience using service design. Elizabeth drove the overall strategy for the Patient Hub and its emphasis on collaboration with outside stakeholders. Her work focuses on how to incorporate design capabilities into a highly-regulated corporate environment, so that design is viewed as a key enabler for getting work done and achieving business value. In particular, she emphasizes the role of co-creation, prototyping, and systems thinking. Having established the strategy and capabilities, Elizabeth now leads a team that applies those design capabilities across the organization

Elizabeth’s Patient Hub role builds on more than 15 years of experience in the pharmaceutical industry, at both Bristol-Myers Squibb and Novo Nordisk. In her previous roles, she has worked on a wide variety of initiatives, including patient support programs, direct marketing campaigns, and development of new technology platforms to support sales teams. Her work spans a variety of therapeutic areas, including diabetes, rheumatoid arthritis, and oncology. Elizabeth holds an economics degree and an MBA.

Michelle Berg

Michelle Berg

VP, Patient Advocacy, Abeona Therapeutics

More information coming soon...

John Mohr

John Mohr

VP, Medical Affairs, Tetraphase Pharmaceuticals

John Mohr is Vice President of Medical Affairs for Tetraphase Pharmaceuticals, a clinical-stage life science company with a fully synthetic chemistry technology based on the tetracycline core chemical structure, that has the potential to address the global health crisis caused by antimicrobial resistance through creation of novel antibiotics for serious and life-threatening bacterial infections. Dr. Mohr is currently responsible for building the Medical Affairs capabilities to allow for the generation, communication and dissemination of medical and clinical information on pipeline and marketed products, the diseases these products treat and non-product information that supports the vision of the company.

Speaker_Name

Melva Covington

Senior Director, Strategy Lead – Global Field Medical Operations for Diabetes and Cardiovascular , Sanofi

Dr. Covington is currently a Senior Director, Field Medical Strategy Lead in the Diabetes Cardiovascular Disease Business Unit at Sanofi. She has held various leadership roles within the Global R&D and Medical Affairs organizations at Sanofi since 2010. Her leadership skills, expertise and collaborations in public health, patient access, clinical research and operations have spanned over 20 years, covering the range of lifecycle development and therapeutic areas. She has a background in public health, early intervention, pharmacoeconomics, strategic thinking and business management. Her goal is to apply these skills strategically and innovatively to address complex issues within healthcare systems, organizations and communities. Much of her work focuses on population-based disparities in health outcomes, operations management and cultural competency.

Prior to joining Sanofi, Melva led both Global and US-based teams in Health Outcomes and Pharmacoeconomics across a number of therapeutic areas at Lilly and Roche Labs. She is passionate about assessing integrated data and perceptions contextually and then applying that knowledge for targeted solutions to improve outcomes across diverse patient populations.

She has an A.B. in Politics/Economics from The Catholic University of America, Masters of Public Health in Maternal and Child Health and Ph.D. from the University of North Carolina at Chapel Hill and MBA from Cornell University. Melva has authored numerous publications and is an impassioned public speaker.shar

Susan Vallow

Susan Vallow

Head, Patient Focused Outcomes, GSK

More information coming soon...

Dina Inverso

Dina Inverso

Strategy Leader, Reimbursement and Patient Engagement, CSL Behring

More information coming soon...

Fatima Scipione

Fatima Scipione

Senior Director, Patient Advocacy, Takeda Oncology

More information coming soon...

Kristi Lengyel

Kristi Lengyel

Director, Patient Advocacy, UCB

More information coming soon...

David Davidovic

David Davidovic

Founder, pathForward LLC

More information coming soon...

Jill Donahue

Jill Donahue

Co-Founder, The Aurora Project

More information coming soon...

Roseanne Durril

Roseanne Durril

Associate Director, Corporate Communications, Takeda

More information coming soon...

Ramana Sonty

Ramana Sonty, MBBS, PhD

Director of Strategy, Janssen

Ramana Sonty, MBBS, PhD, is a Director of Strategy, in the Janssen Global Medical Organization. He is a leader on the J&J Pre-Approval Access Task Force in the Office of the CMO. The Task Force has delivered a new Janssen pre-approval access policy, a new SOP and implemented global tracking processes for expanded access / compassionate use requests. In addition, he has led multiple external stakeholder engagements and is part of the team that launched an innovative compassionate use pilot with NYU, called CompAC, in 2015. The pilot has been featured in articles in Nature, JAMA and other publications. He has presented the work of the Task force to diverse national and international audiences. Ramana has trained in Medicine and Neuroscience.

David Fortanbary

David Fortanbary

Head of North America Commercial Training, UCB

More information coming soon...

Jodie Gillon

Jodie Gillon

Senior Director, Advocacy and Professional Society Affairs, Achillion

More information coming soon...

Wendy Erler

Wendy Erler

Vice President Patient Advocacy and Market Insights, WAVE Life Sciences

More information coming soon...

Jon Michaeli

Jon Michaeli

EVP Marketing & Business Development, Medisafe

More information coming soon...

Brenda Snow

Brenda Snow

Founder & CEO, Snow Companies

More information coming soon...

Jan Liska

Jan Liska

Global Head of Patient Business Strategy, Sanofi

More information coming soon...

Nareda Mills

Nareda Mills

Senior VP, Clinical Services, Ashfield Clinical

More information coming soon...

ashik_desai

Ashik Desai

EVP of Business Growth and Analytics, CONTEXTMEDIA:HEALTH

More information coming soon...

jim o'donoghue

Jim O'Donoghue

Vice President, S3 Connected Health

More information coming soon...

Jennifer Strassburger

Jennifer Strassburger

Sr. Director, Healthcare, Clear

More information coming soon...

Jitesh Rohatgi

Jitesh Rohatgi

Director, Global Industry Principal - Life Sciences, Pegasystems

Jitesh has over 16 years of experience in managing business and technology aspects of customer engagement and compliance solutions for life sciences industry. As the Director- Global Industry Principal, Jitesh is responsible for product strategy, marketing and thought leadership for customer engagement in life sciences for Pega. Prior to joining Pega, Jitesh worked in various leadership roles in product management, solution consulting and technology for Cegedim (Now IMS Health). In his career, he has interacted with 200+ unique life sciences organizations, sharing his expertise in the life sciences domain with customers in specific sales and consulting engagements. He lives in Allentown PA with his family and loves watching/playing tennis whenever possible.

Bobbie Montgomery

Bobbie Montgomery

Senior Director, Business Development, Commercial North America, QuintilesIMS

More information coming soon...

Javier Castillo

Javier Castillo, R.Ph.

Executive Director, Program Design & Strategy, Health Management Solutions, QuintilesIMS

More information coming soon...

Jean McCoy

Jean McCoy

Senior Vice President of Strategy and Innovation, Health Advocacy Strategies

More information coming soon...

The Patient Voice

Marc Boutin

Marc Boutin

CEO, National Health Council

More information coming soon...

Paul Gileno

Paul Gileno

Founder and President, US Pain Foundation

Paul Gileno is a strong force in the chronic pain awareness movement. His mission in life is to empower and support those living with pain. Having pain himself makes the issue of pain care a personal and public matter for him. After a work injury in 2003 left him living with degenerative disc disease, failed back syndrome and complex regional pain syndrome for over three years, Paul created U.S. Pain Foundation.

U.S. Pain is a 501c(3) nonprofit that exists to connect, inform, empower and advocate for the pain community. This grassroots organization continues to grow with over 70,000 members with representation in every state.

As the integral force behind the U.S. Pain Foundation team, Paul is determined to improve healthcare and make a difference. He believes that by exploring new ways to cope, those with pain can find personal answers that enable them to grow and live once more with meaning and purpose. Furthermore, he is committed to making sure the public better understands the tolls and trials those with pain endure. He validates pain and empowers the 100 million Americans suffering to become educated and proactive.

Striving to design programs that are informative and relevant to the pain community, he was the mastermind behind the pain warrior bracelet. This initiative unites, strengthens, validates and encourages the pain community to keep fighting for proper care. He was also one of the visionaries for the INvisible Project. The INvisible Project is a national campaign that illustrates the struggles and resilience of those with pain through photography and story. Additionally, he was instrumental behind the passing of Connecticut’s Act 11-169; legislation that has had a direct benefit on the medical care Connecticut residents living with chronic pain receive.

Besides his work with U.S. Pain, Paul is on the Advisory Board for PainPathways magazine. He also supports various organizations that raise awareness and fund research on behalf of the chronic pain community, as all endeavors shift perceptions about pain and motivate change. In May 2014, he was the recipient of the Unsung Hero Award for his stellar work in pain policy initiatives as well as his significant contributions to advance the social awareness of pain and suffering. Paul additionally received the “2015 Educator of the Year Award” from the American Society of Pain Educators (ASPE).

He resides in New York with his wife and two sons.

Sarah Krüg

Sarah Krüg

CEO, CANCER101

More information coming soon...

Katherine Sharpe

Katherine Sharpe

SVP, Patient and Caregiver Support, American Cancer Society

Katherine Sharpe is the Senior Vice President of Patient and Caregiver Support and has been with the Society since 1997, serving most recently as vice president of Health Systems for the South Atlantic Division, where she’s provided leadership for the vision, direction, and strategy for health systems, including mission deployment through primary care, hospital, and state-based systems.

As the SVP for Patient and Caregiver Support, Katherine provides strategic direction for the Society’s patient and caregiver support, as well as post treatment survivorship initiatives (interventions, campaigns, programs, services and products); overseeing strategic, integrated, comprehensive planning for and execution of patient/caregiver/post treatment survivorship initiatives at all levels of the organization; and ensuring initiatives are evidenced-based, regularly evaluated for impact and quality improvement, and consistent with the patient support/survivorship goals and objectives set by the National Board of Directors. Katherine previously served as the Society’s managing director of Prevention and Survivorship Strategy, where she provided key leadership in establishing the National Cancer Survivorship Resource Center – allowing the Society to help shape the future of survivorship care and improve the quality of life of cancer survivors after treatment. While in that role, Katherine led a team that facilitated the development of clinical guidance for post-treatment survivorship care, developing strategies to enhance provider and survivor education and establishing survivorship as a priority for public health policy.

Prior to her tenure with ACS, Katherine worked as a case manager and counselor in a variety of clinical settings, including Children’s Medical Center, Dallas, TX, the Scottish Rite Hospital, Dallas, TX and the Austin State Hospital, Austin, TX.

Katherine holds an undergraduate degree in Psychology from St. Mary College, a master’s degree from Seabury-Western, Evanston, Illinois and a post graduate certificate in Public Health from the University of Florida.

Steve L. Morin

Steve L. Morin

Health Programs Coordinator and Director, Patient Network, FDA

Commander (CDR) Steve L. Morin received a Bachelor of Science in Nursing from the University of Southern Maine in December 1997. Following his graduation, CDR Morin worked as a staff oncology nurse at Maine Medical Center and the National Institutes of Health (NIH) and a research nurse for the National Cancer Institute.

He worked as the Infection Control Officer for Department of Homeland Security from 2005-2009 and coordinated continuation of care for newly diagnosed tuberculosis patients and earned his flight wings in the United States Air Force and assisted with the coordination of care for critically ill undocumented residents. CDR Morin joined the FDA in 2009 and worked in the Office of Surveillance and Epidemiology where he performed Medication Guide and Patient Package Insert reviews for the Patient Labeling & Education Team. Since 2011 he has been in the Office of Health and Constituent Affairs where he works closely with numerous Patients and Patient Advocate Groups in helping them understand the regulatory process, medical product approval process, expanded access, and other topics important to patients. He also assists with the Patient Representative Program, handling telephone and email communications from patients and the public. CDR Morin currently manages the FDA Patient Network that includes the For Patient website, FDA Patient Network Newsletter, @FDA_Patient_Net twitter account

Brenda Hawkes

Brenda Hawkes

Senior Manager, Patient Advocacy, Diplomat

Brenda Hawkes is the senior manager of patient advocacy at Diplomat. She leads Diplomat’s efforts for patient advocacy by reaching out to support groups nationwide, teaching empathy training to fellow employees and keeping a keen eye on what patients need for their healthcare. Within Diplomat Brenda serves as the “voice of the patient” by always reminding the different business areas that patients hear and think differently than sales people or clinicians.

Brenda has more than 18 years of experience working in leadership, fundraising and program development. Before working at Diplomat, she established and served as the executive director for Our Promise Cancer Resources, a 501c3 organization that provides non-medical support to cancer patients and their families in south-central Arkansas. Additionally, Brenda has extensive background in community relations and developing collaborative opportunities between different stakeholders.

From personal experience, Hawkes brings an intimate understanding of what it means to be a patient. In 2006, Brenda was diagnosed with stage III triple negative breast cancer; she faced chemotherapy, radiation and nine surgeries, and is now a survivor. During this time she also found she has the BRCA1 mutation. She also has been a caregiver, for her husband, David, who underwent treatment for colon cancer in 2002.

As a survivor and patient advocate, Brenda is a testament to the need for patient support, and to the power of care and hope. She and her husband live in Fenton, MI and are proud parents of two daughters, Meghan and Erin.

T.J. Sharpe

T.J. Sharpe

Writer, Advocate, Stage IV Melanoma Survivor, & Author of Patient #1 Blog, www.philly.com

T.J. Sharpe is a Stage IV melanoma patient who shares his journey through cancer in the Patient #1 Blog on www.philly.com. He was diagnosed in August 2012 with melanoma tumors in multiple organs; since then, he has undergone six surgeries and four immunotherapy treatments over two different clinical trials. The initial failures, and subsequent significant positive response, have been chronicled in his blog posts since January 2013. His is a story about life with a serious illness and the mental and emotional hurdles a patient must clear. He writes how a cancer patient’s challenges mirror those many face, and portrays life through the optimistic prism of a patient who is on the long, winding road towards overcoming melanoma’s long odds and deadly consequences. He also shares the latest melanoma and cancer research breakthroughs, and advocacy events and initiatives to help others avoid, detect, or educate themselves on cancer. A South Jersey native, T.J. lives in Fort Lauderdale with his wife Jennifer and two young children, Josie and Tommy.

Jack Whelan

Jack Whelan

Research Advocate, Principal, & Event Speaker, Jack-Whelan LLC

More information coming soon...

Sabina Kineen

Sabina Kineen

Patient Advocate and Caregiver, Fabry Disease

Diagnosed with Fabry Disease in her early teens, Sabina Kineen provides a unique perspective as both a patient and caregiver. Over the years, she has shared her experiences living with a rare genetic condition, as well as helping manage the complicated and multi-faceted healthcare needs of herself, her parents and two of her children. Sabina has participated in patient meetings throughout the country and has presented at various industry sponsored events. Her main passion remains educating others how the diagnosis of an inherited, rare disease can affect not only a single patient, but an entire family.

Mary Dunkle

Mary Dunkle

Vice President for Educational Initiatives, National Organization for Rare Disorders

More information coming soon...

Kimberly Jewett

Kimberly Jewett

CEO & Founder, Kimberly Jewett Consulting Inc

Kimberly Jewett is a two-time breast cancer survivor, and CEO of Kimberly Jewett Consulting, Inc. She received her initial diagnosis when she was only 31 years old, and again at 35. Currently, doctors have declared her with no evidence of disease. Kimberly attributes her survivorship to her faith, strength, hope, and passion. Kimberly believes that by sharing her story, she will continue to inspire, empower, and educate patients to "use their voice and to be their own best advocate" in their healthcare decisions to ensure better outcomes and compliance.

Felicia S. Johnson

Felicia S. Johnson

Patient Advocate, Living Beyond Breast Cancer

More information coming soon...

MarlaJan DeFusco

MarlaJan DeFusco

Patient, Lupus Advocate and Blogger, Luck Fupus

More information coming soon...

All Speakers

Lisa Egbuonu-Davis

Lisa Egbuonu-Davis

VP, Global Patient Centered Outcomes and Solution, Sanofi

More information coming soon...

Dr. Christopher Boerner

Dr. Christopher Boerner

President and Head of US Commercial, Bristol-Myers Squibb

Dr. Christopher Boerner is currently the President and Head of the U.S. Commercial business at Bristol-Myers Squibb. He joined BMS in February 2015. Prior to this role, Dr. Boerner served as the Executive Vice President of Commercial for Seattle Genetics, Inc., where he was responsible for leading all commercial activities for the company. Previously, he was its Senior Vice President of Commercial and its Vice President of Marketing. Before joining Seattle Genetics, Dr. Boerner was with Dendreon Corporation, where he led the marketing team.From 2002 to 2010, he was with Genentech, a member of the Roche Group, where he served in a variety of commercial roles, including Director of Marketing on Avastin, Director of Avastin franchise strategy and Associate Director of Oncology Market Development.Prior to Genentech, Dr. Boerner was with McKinsey & Company, a global strategic management consulting firm, where he served global pharmaceutical and biotechnology clients.

Dr. Boerner received his PhD and M.A. in Business Administration from the Haas School of Business at the University of California, Berkeley, and holds an A.B. in Economics and History from Washington University in St. Louis.

Elizabeth Turcotte

Elizabeth Turcotte

Director, Patient Hub, BMS

Elizabeth Turcotte is the Director of the Patient Hub at Bristol-Myers Squibb. In this role, she supports the entire organization in delivering improved patient experience using service design. Elizabeth drove the overall strategy for the Patient Hub and its emphasis on collaboration with outside stakeholders. Her work focuses on how to incorporate design capabilities into a highly-regulated corporate environment, so that design is viewed as a key enabler for getting work done and achieving business value. In particular, she emphasizes the role of co-creation, prototyping, and systems thinking. Having established the strategy and capabilities, Elizabeth now leads a team that applies those design capabilities across the organization

Elizabeth’s Patient Hub role builds on more than 15 years of experience in the pharmaceutical industry, at both Bristol-Myers Squibb and Novo Nordisk. In her previous roles, she has worked on a wide variety of initiatives, including patient support programs, direct marketing campaigns, and development of new technology platforms to support sales teams. Her work spans a variety of therapeutic areas, including diabetes, rheumatoid arthritis, and oncology. Elizabeth holds an economics degree and an MBA.

Michelle Berg

Michelle Berg

VP, Patient Advocacy, Abeona Therapeutics

More information coming soon...

John Mohr

John Mohr

VP, Medical Affairs, Tetraphase Pharmaceuticals

John Mohr is Vice President of Medical Affairs for Tetraphase Pharmaceuticals, a clinical-stage life science company with a fully synthetic chemistry technology based on the tetracycline core chemical structure, that has the potential to address the global health crisis caused by antimicrobial resistance through creation of novel antibiotics for serious and life-threatening bacterial infections. Dr. Mohr is currently responsible for building the Medical Affairs capabilities to allow for the generation, communication and dissemination of medical and clinical information on pipeline and marketed products, the diseases these products treat and non-product information that supports the vision of the company.

Speaker_Name

Melva Covington

Senior Director, Strategy Lead – Global Field Medical Operations for Diabetes and Cardiovascular , Sanofi

Dr. Covington is currently a Senior Director, Field Medical Strategy Lead in the Diabetes Cardiovascular Disease Business Unit at Sanofi. She has held various leadership roles within the Global R&D and Medical Affairs organizations at Sanofi since 2010. Her leadership skills, expertise and collaborations in public health, patient access, clinical research and operations have spanned over 20 years, covering the range of lifecycle development and therapeutic areas. She has a background in public health, early intervention, pharmacoeconomics, strategic thinking and business management. Her goal is to apply these skills strategically and innovatively to address complex issues within healthcare systems, organizations and communities. Much of her work focuses on population-based disparities in health outcomes, operations management and cultural competency.

Prior to joining Sanofi, Melva led both Global and US-based teams in Health Outcomes and Pharmacoeconomics across a number of therapeutic areas at Lilly and Roche Labs. She is passionate about assessing integrated data and perceptions contextually and then applying that knowledge for targeted solutions to improve outcomes across diverse patient populations.

She has an A.B. in Politics/Economics from The Catholic University of America, Masters of Public Health in Maternal and Child Health and Ph.D. from the University of North Carolina at Chapel Hill and MBA from Cornell University. Melva has authored numerous publications and is an impassioned public speaker.shar

Susan Vallow

Susan Vallow

Head, Patient Focused Outcomes, GSK

More information coming soon...

Dina Inverso

Dina Inverso

Strategy Leader, Reimbursement and Patient Engagement, CSL Behring

More information coming soon...

Fatima Scipione

Fatima Scipione

Senior Director, Patient Advocacy, Takeda Oncology

More information coming soon...

Kristi Lengyel

Kristi Lengyel

Director, Patient Advocacy, UCB

More information coming soon...

David Davidovic

David Davidovic

Founder, pathForward LLC

More information coming soon...

Jill Donahue

Jill Donahue

Co-Founder, The Aurora Project

More information coming soon...

Roseanne Durril

Roseanne Durril

Associate Director, Corporate Communications, Takeda

More information coming soon...

Ramana Sonty

Ramana Sonty, MBBS, PhD

Director of Strategy, Janssen

Ramana Sonty, MBBS, PhD, is a Director of Strategy, in the Janssen Global Medical Organization. He is a leader on the J&J Pre-Approval Access Task Force in the Office of the CMO. The Task Force has delivered a new Janssen pre-approval access policy, a new SOP and implemented global tracking processes for expanded access / compassionate use requests. In addition, he has led multiple external stakeholder engagements and is part of the team that launched an innovative compassionate use pilot with NYU, called CompAC, in 2015. The pilot has been featured in articles in Nature, JAMA and other publications. He has presented the work of the Task force to diverse national and international audiences. Ramana has trained in Medicine and Neuroscience.

David Fortanbary

David Fortanbary

Head of North America Commercial Training, UCB

More information coming soon...

Jodie Gillon

Jodie Gillon

Senior Director, Advocacy and Professional Society Affairs, Achillion

More information coming soon...

Wendy Erler

Wendy Erler

Vice President Patient Advocacy and Market Insights, WAVE Life Sciences

More information coming soon...

Jon Michaeli

Jon Michaeli

EVP Marketing & Business Development, Medisafe

More information coming soon...

Brenda Snow

Brenda Snow

Founder & CEO, Snow Companies

More information coming soon...

Jan Liska

Jan Liska

Global Head of Patient Business Strategy, Sanofi

More information coming soon...

Nareda Mills

Nareda Mills

Senior VP, Clinical Services, Ashfield Clinical

More information coming soon...

ashik_desai

Ashik Desai

EVP of Business Growth and Analytics, CONTEXTMEDIA:HEALTH

More information coming soon...

jim o'donoghue

Jim O'Donoghue

Vice President, S3 Connected Health

More information coming soon...

Jennifer Strassburger

Jennifer Strassburger

Sr. Director, Healthcare, Clear

More information coming soon...

Jitesh Rohatgi

Jitesh Rohatgi

Director, Global Industry Principal - Life Sciences, Pegasystems

Jitesh has over 16 years of experience in managing business and technology aspects of customer engagement and compliance solutions for life sciences industry. As the Director- Global Industry Principal, Jitesh is responsible for product strategy, marketing and thought leadership for customer engagement in life sciences for Pega. Prior to joining Pega, Jitesh worked in various leadership roles in product management, solution consulting and technology for Cegedim (Now IMS Health). In his career, he has interacted with 200+ unique life sciences organizations, sharing his expertise in the life sciences domain with customers in specific sales and consulting engagements. He lives in Allentown PA with his family and loves watching/playing tennis whenever possible.

Bobbie Montgomery

Bobbie Montgomery

Senior Director, Business Development, Commercial North America, QuintilesIMS

More information coming soon...

Javier Castillo

Javier Castillo, R.Ph.

Executive Director, Program Design & Strategy, Health Management Solutions, QuintilesIMS

More information coming soon...

Jean McCoy

Jean McCoy

Senior Vice President of Strategy and Innovation, Health Advocacy Strategies

More information coming soon...

Marc Boutin

Marc Boutin

CEO, National Health Council

More information coming soon...

Paul Gileno

Paul Gileno

Founder and President, US Pain Foundation

Paul Gileno is a strong force in the chronic pain awareness movement. His mission in life is to empower and support those living with pain. Having pain himself makes the issue of pain care a personal and public matter for him. After a work injury in 2003 left him living with degenerative disc disease, failed back syndrome and complex regional pain syndrome for over three years, Paul created U.S. Pain Foundation.

U.S. Pain is a 501c(3) nonprofit that exists to connect, inform, empower and advocate for the pain community. This grassroots organization continues to grow with over 70,000 members with representation in every state.

As the integral force behind the U.S. Pain Foundation team, Paul is determined to improve healthcare and make a difference. He believes that by exploring new ways to cope, those with pain can find personal answers that enable them to grow and live once more with meaning and purpose. Furthermore, he is committed to making sure the public better understands the tolls and trials those with pain endure. He validates pain and empowers the 100 million Americans suffering to become educated and proactive.

Striving to design programs that are informative and relevant to the pain community, he was the mastermind behind the pain warrior bracelet. This initiative unites, strengthens, validates and encourages the pain community to keep fighting for proper care. He was also one of the visionaries for the INvisible Project. The INvisible Project is a national campaign that illustrates the struggles and resilience of those with pain through photography and story. Additionally, he was instrumental behind the passing of Connecticut’s Act 11-169; legislation that has had a direct benefit on the medical care Connecticut residents living with chronic pain receive.

Besides his work with U.S. Pain, Paul is on the Advisory Board for PainPathways magazine. He also supports various organizations that raise awareness and fund research on behalf of the chronic pain community, as all endeavors shift perceptions about pain and motivate change. In May 2014, he was the recipient of the Unsung Hero Award for his stellar work in pain policy initiatives as well as his significant contributions to advance the social awareness of pain and suffering. Paul additionally received the “2015 Educator of the Year Award” from the American Society of Pain Educators (ASPE).

He resides in New York with his wife and two sons.

Sarah Krüg

Sarah Krüg

CEO, CANCER101

More information coming soon...

Katherine Sharpe

Katherine Sharpe

SVP, Patient and Caregiver Support, American Cancer Society

Katherine Sharpe is the Senior Vice President of Patient and Caregiver Support and has been with the Society since 1997, serving most recently as vice president of Health Systems for the South Atlantic Division, where she’s provided leadership for the vision, direction, and strategy for health systems, including mission deployment through primary care, hospital, and state-based systems.

As the SVP for Patient and Caregiver Support, Katherine provides strategic direction for the Society’s patient and caregiver support, as well as post treatment survivorship initiatives (interventions, campaigns, programs, services and products); overseeing strategic, integrated, comprehensive planning for and execution of patient/caregiver/post treatment survivorship initiatives at all levels of the organization; and ensuring initiatives are evidenced-based, regularly evaluated for impact and quality improvement, and consistent with the patient support/survivorship goals and objectives set by the National Board of Directors. Katherine previously served as the Society’s managing director of Prevention and Survivorship Strategy, where she provided key leadership in establishing the National Cancer Survivorship Resource Center – allowing the Society to help shape the future of survivorship care and improve the quality of life of cancer survivors after treatment. While in that role, Katherine led a team that facilitated the development of clinical guidance for post-treatment survivorship care, developing strategies to enhance provider and survivor education and establishing survivorship as a priority for public health policy.

Prior to her tenure with ACS, Katherine worked as a case manager and counselor in a variety of clinical settings, including Children’s Medical Center, Dallas, TX, the Scottish Rite Hospital, Dallas, TX and the Austin State Hospital, Austin, TX.

Katherine holds an undergraduate degree in Psychology from St. Mary College, a master’s degree from Seabury-Western, Evanston, Illinois and a post graduate certificate in Public Health from the University of Florida.

Steve L. Morin

Steve L. Morin

Health Programs Coordinator and Director, Patient Network, FDA

Commander (CDR) Steve L. Morin received a Bachelor of Science in Nursing from the University of Southern Maine in December 1997. Following his graduation, CDR Morin worked as a staff oncology nurse at Maine Medical Center and the National Institutes of Health (NIH) and a research nurse for the National Cancer Institute.

He worked as the Infection Control Officer for Department of Homeland Security from 2005-2009 and coordinated continuation of care for newly diagnosed tuberculosis patients and earned his flight wings in the United States Air Force and assisted with the coordination of care for critically ill undocumented residents. CDR Morin joined the FDA in 2009 and worked in the Office of Surveillance and Epidemiology where he performed Medication Guide and Patient Package Insert reviews for the Patient Labeling & Education Team. Since 2011 he has been in the Office of Health and Constituent Affairs where he works closely with numerous Patients and Patient Advocate Groups in helping them understand the regulatory process, medical product approval process, expanded access, and other topics important to patients. He also assists with the Patient Representative Program, handling telephone and email communications from patients and the public. CDR Morin currently manages the FDA Patient Network that includes the For Patient website, FDA Patient Network Newsletter, @FDA_Patient_Net twitter account

Brenda Hawkes

Brenda Hawkes

Senior Manager, Patient Advocacy, Diplomat

Brenda Hawkes is the senior manager of patient advocacy at Diplomat. She leads Diplomat’s efforts for patient advocacy by reaching out to support groups nationwide, teaching empathy training to fellow employees and keeping a keen eye on what patients need for their healthcare. Within Diplomat Brenda serves as the “voice of the patient” by always reminding the different business areas that patients hear and think differently than sales people or clinicians.

Brenda has more than 18 years of experience working in leadership, fundraising and program development. Before working at Diplomat, she established and served as the executive director for Our Promise Cancer Resources, a 501c3 organization that provides non-medical support to cancer patients and their families in south-central Arkansas. Additionally, Brenda has extensive background in community relations and developing collaborative opportunities between different stakeholders.

From personal experience, Hawkes brings an intimate understanding of what it means to be a patient. In 2006, Brenda was diagnosed with stage III triple negative breast cancer; she faced chemotherapy, radiation and nine surgeries, and is now a survivor. During this time she also found she has the BRCA1 mutation. She also has been a caregiver, for her husband, David, who underwent treatment for colon cancer in 2002.

As a survivor and patient advocate, Brenda is a testament to the need for patient support, and to the power of care and hope. She and her husband live in Fenton, MI and are proud parents of two daughters, Meghan and Erin.

T.J. Sharpe

T.J. Sharpe

Writer, Advocate, Stage IV Melanoma Survivor, & Author of Patient #1 Blog, www.philly.com

T.J. Sharpe is a Stage IV melanoma patient who shares his journey through cancer in the Patient #1 Blog on www.philly.com. He was diagnosed in August 2012 with melanoma tumors in multiple organs; since then, he has undergone six surgeries and four immunotherapy treatments over two different clinical trials. The initial failures, and subsequent significant positive response, have been chronicled in his blog posts since January 2013. His is a story about life with a serious illness and the mental and emotional hurdles a patient must clear. He writes how a cancer patient’s challenges mirror those many face, and portrays life through the optimistic prism of a patient who is on the long, winding road towards overcoming melanoma’s long odds and deadly consequences. He also shares the latest melanoma and cancer research breakthroughs, and advocacy events and initiatives to help others avoid, detect, or educate themselves on cancer. A South Jersey native, T.J. lives in Fort Lauderdale with his wife Jennifer and two young children, Josie and Tommy.

Jack Whelan

Jack Whelan

Research Advocate, Principal, & Event Speaker, Jack-Whelan LLC

More information coming soon...

Sabina Kineen

Sabina Kineen

Patient Advocate and Caregiver, Fabry Disease

Diagnosed with Fabry Disease in her early teens, Sabina Kineen provides a unique perspective as both a patient and caregiver. Over the years, she has shared her experiences living with a rare genetic condition, as well as helping manage the complicated and multi-faceted healthcare needs of herself, her parents and two of her children. Sabina has participated in patient meetings throughout the country and has presented at various industry sponsored events. Her main passion remains educating others how the diagnosis of an inherited, rare disease can affect not only a single patient, but an entire family.

Mary Dunkle

Mary Dunkle

Vice President for Educational Initiatives, National Organization for Rare Disorders

More information coming soon...

Kimberly Jewett

Kimberly Jewett

CEO & Founder, Kimberly Jewett Consulting Inc

Kimberly Jewett is a two-time breast cancer survivor, and CEO of Kimberly Jewett Consulting, Inc. She received her initial diagnosis when she was only 31 years old, and again at 35. Currently, doctors have declared her with no evidence of disease. Kimberly attributes her survivorship to her faith, strength, hope, and passion. Kimberly believes that by sharing her story, she will continue to inspire, empower, and educate patients to "use their voice and to be their own best advocate" in their healthcare decisions to ensure better outcomes and compliance.

Felicia S. Johnson

Felicia S. Johnson

Patient Advocate, Living Beyond Breast Cancer

More information coming soon...

MarlaJan DeFusco

MarlaJan DeFusco

Patient, Lupus Advocate and Blogger, Luck Fupus

More information coming soon...

Pre-order the detailed event brochure

Complete speaker line-up • Program for all tracks & sessions • Audience breakdown